Tower Research Capital LLC (TRC) - OPIANT PHARMACEUTICALS INC ownership

OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 41 filers reported holding OPIANT PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of OPIANT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$15
-99.6%
744
+71.4%
0.00%
Q3 2022$4,000
-75.0%
434
-68.3%
0.00%
Q2 2022$16,000
+433.3%
1,369
+789.0%
0.00%
Q1 2022$3,000
-25.0%
154
+11.6%
0.00%
Q3 2021$4,000
+33.3%
138
-46.5%
0.00%
Q2 2021$3,0000.0%258
-8.8%
0.00%
Q1 2021$3,000
-57.1%
283
-69.1%
0.00%
Q4 2020$7,000
+133.3%
916
+187.1%
0.00%
Q3 2020$3,000
-91.2%
319
-91.4%
0.00%
-100.0%
Q2 2020$34,0003,7270.00%
Other shareholders
OPIANT PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 112,000$2,399,0002.90%
Ovata Capital Management Ltd 117,865$2,525,0000.78%
HealthInvest Partners AB 18,000$386,0000.62%
PERRITT CAPITAL MANAGEMENT INC 30,500$653,0000.35%
Parkman Healthcare Partners LLC 32,557$697,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 32,040$686,0000.08%
DLD Asset Management, LP 20,000$428,0000.03%
Newbridge Financial Services Group, Inc. 2,050$44,0000.02%
Trexquant Investment LP 12,013$257,0000.01%
BAILARD, INC. 15,042$322,0000.01%
View complete list of OPIANT PHARMACEUTICALS INC shareholders